BSE filing, NSE: EIDPARRY. Summary written from the filing by ALFA Finder's alert engine.
EID Parry (India) Ltd: key numbers
- Share price
- ₹624.65
- Market cap
- ₹11,116 Cr
- Revenue (annual)
- ₹38,534 Cr
- Net profit (annual)
- ₹569.5 Cr
- P/E (TTM)
- 23.9×Sector 26.8×
- Promoter holding
- 41.28%+0.00% QoQ
- FII holding
- 9.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from EID Parry (India) Ltd
All →EID Parry (India) Management Change
Chandrasekar V R, Sr. AVP and Chief Information Officer (CIO) of E.I.D.- Parry (India) Limited, has resigned effective December 31, 2026.
EID Parry (India) Other Announcement
EID Parry India Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026. The filing includes details on changes in promoter/promoter group holdings.
EID Parry (India) Capital Structure Change
SBI Mutual Fund increased its stake in EID Parry India Ltd by purchasing 78,142 shares. Its total shareholding now stands at 9.1363%.
EID Parry (India) Other Announcement
CRISIL ESG Ratings & Analytics has independently assigned an ESG rating of 61 (Strong) to E.I.D. - Parry (India) Limited for FY 2025-26.
EID Parry (India) Earnings Call Transcript: Key Takeaways
Management pivots to margin-accretion via CPG restructuring and Neutra growth as core sugar operations face feedstock shortages and rising cane costs in TN/AP.
EID Parry (India) Annual General Meeting
E.I.D. - Parry (India) Limited held its 51st Annual General Meeting on August 12, 2026, where shareholders adopted financial statements and approved subsidiary asset disposal.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.